---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292117478.md"
description: "During Wednesday's after-market session, several healthcare stocks experienced significant movements. Gainers included OSR Health (+7.2%), BioRestorative Therapies (+7.12%), NextCure (+6.08%), Tempest Therapeutics (+5.33%), Rafael Holdings (+4.89%), and Icecure Medical (+4.88%). Conversely, losers featured Catheter Precision (-15.3%), Cibus (-9.35%), Tvardi Therapeutics (-9.01%), Decoy Therapeutics (-7.83%), Aptevo Therapeutics (-7.64%), and Lexaria Bioscience (-7.44%)."
datetime: "2026-07-08T21:05:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292117478.md)
  - [en](https://longbridge.com/en/news/292117478.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292117478.md)
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **OSR Health** (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million.
-   **BioRestorative Therapies** (NASDAQ:BRTX) stock moved upwards by 7.12% to $0.37. The market value of their outstanding shares is at $9.4 million.
-   **NextCure** (NASDAQ:NXTC) shares moved upwards by 6.08% to $1.85. The market value of their outstanding shares is at $6.4 million.
-   **Tempest Therapeutics** (NASDAQ:TPST) shares rose 5.33% to $1.04. The company's market cap stands at $15.8 million.
-   **Rafael Holdings** (NYSE:RFL) stock rose 4.89% to $2.57. The market value of their outstanding shares is at $121.6 million.
-   **Icecure Medical** (NASDAQ:ICCM) shares increased by 4.88% to $4.29. The company's market cap stands at $14.3 million.

### Losers

-   **Catheter Precision** (AMEX:VTAK) shares decreased by 15.3% to $1.16 during Wednesday's after-market session. The company's market cap stands at $2.5 million.
-   **Cibus** (NASDAQ:CBUS) shares fell 9.35% to $1.65. The market value of their outstanding shares is at $114.4 million.
-   **Tvardi Therapeutics** (NASDAQ:TVRD) shares fell 9.01% to $4.55. The company's market cap stands at $29.0 million.
-   **Decoy Therapeutics** (NASDAQ:DCOY) shares fell 7.83% to $5.3. The company's market cap stands at $3.7 million.
-   **Aptevo Therapeutics** (NASDAQ:APVO) shares fell 7.64% to $4.12. The company's market cap stands at $5.6 million.
-   **Lexaria Bioscience** (NASDAQ:LEXX) shares declined by 7.44% to $0.56. The market value of their outstanding shares is at $13.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [APVO.US](https://longbridge.com/en/quote/APVO.US.md)
- [BRTX.US](https://longbridge.com/en/quote/BRTX.US.md)
- [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md)
- [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md)
- [CBUS.US](https://longbridge.com/en/quote/CBUS.US.md)
- [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md)
- [ICCM.US](https://longbridge.com/en/quote/ICCM.US.md)
- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [TVRD.US](https://longbridge.com/en/quote/TVRD.US.md)
- [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md)
- [TPST.US](https://longbridge.com/en/quote/TPST.US.md)
- [RFL.US](https://longbridge.com/en/quote/RFL.US.md)
- [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)

## Related News & Research

- [Aptevo targets solid tumors with planned Nectin-4 x PD-L1 dual-targeting platform strategy](https://longbridge.com/en/news/293969770.md)
- [BioRestorative Therapies files Form 3 initial beneficial ownership statement for director Steven Collier Brown](https://longbridge.com/en/news/293789082.md)
- [Decoy Therapeutics expands IP portfolio with 1 granted US patent, 19 applications pending](https://longbridge.com/en/news/294697289.md)
- [Tvardi Therapeutics plans 2027 mid-to-late stage ulcerative colitis trial for STAT3 inhibitor TTI-109](https://longbridge.com/en/news/294357121.md)
- [Catheter Precision raises $2.82 million in unregistered sale of Series C-4 preferred stock](https://longbridge.com/en/news/294557836.md)